|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-3-3
|
|
pubmed:abstractText |
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) allows analysis of both tumor volume and contrast enhancement pattern using a single tool. We sought to investigate whether DCE-MRI could be used to predict histological response in patients undergoing primary chemotherapy (PCT) for breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0167-6806
|
|
pubmed:author |
pubmed-author:AgliettaMassimoM,
pubmed-author:BigliaNicolettaN,
pubmed-author:CirilloStefanoS,
pubmed-author:De RosaGiovanniG,
pubmed-author:GattiMarcoM,
pubmed-author:MarraVincenzoV,
pubmed-author:MartincichLauraL,
pubmed-author:MontemurroFilippoF,
pubmed-author:PonzoneRiccardoR,
pubmed-author:ReggeDanieleD,
pubmed-author:SarottoIvanaI,
pubmed-author:SismondiPieroP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-76
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14997056-Adolescent,
pubmed-meshheading:14997056-Adult,
pubmed-meshheading:14997056-Aged,
pubmed-meshheading:14997056-Anthracyclines,
pubmed-meshheading:14997056-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14997056-Breast Neoplasms,
pubmed-meshheading:14997056-Bridged Compounds,
pubmed-meshheading:14997056-Contrast Media,
pubmed-meshheading:14997056-Female,
pubmed-meshheading:14997056-Humans,
pubmed-meshheading:14997056-Image Processing, Computer-Assisted,
pubmed-meshheading:14997056-Magnetic Resonance Imaging,
pubmed-meshheading:14997056-Middle Aged,
pubmed-meshheading:14997056-Neoadjuvant Therapy,
pubmed-meshheading:14997056-Neoplasm Staging,
pubmed-meshheading:14997056-Predictive Value of Tests,
pubmed-meshheading:14997056-Taxoids
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.
|
|
pubmed:affiliation |
Department of Diagnostic Imaging, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
